Yes, we are still very much here. But we are spending time reviewing interesting story possibilities and meeting with interesting people. However, we do not want to let interesting items get away from us - or you. So here are a few worth noting…

The House Energy & Commerce Committee is now also investigating an FDA no-bid public relations contract awarded a firm with ties to one or more FDA personnel. You can read the letter to FDA commish Andy von Eschenbach here.

Johnson & Johnson passed on the chance to renew its lucrative global sponsorship deal with the Olympics. The International Olympics Committee confirmed that the health care giant would not renew its top-level sponsorship, which worth up to $100 million, according to Sports Business Journal.

AstraZeneca named Rich Fante president of its US business, replacing Tony Zook, who was recently named president of MedImmune, which the drugmaker acquired last year. Zook also is ceo of AZ North America and head of global marketing. Fante previously led marketing for all AZ brands in the US as vp brand strategy and portfolio operations.